Duration of dual antiplatelet therapy and stability of coronary heart disease: a 60 000-patient meta-analysis of randomised controlled trials
Background Dual antiplatelet therapy (DAPT) has important implications for clinical outcomes in coronary disease. However, the optimal DAPT duration remains uncertain.Methods and results We searched four major databases for randomised controlled trials comparing long-term (≥12 months) with short-ter...
Saved in:
| Main Authors: | David E Newby, Nicholas L Mills, Kuan Ken Lee, Anoop S V Shah, Mohammed N Meah, Anda Bularga, Dimitrios Doudesis |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2021-12-01
|
| Series: | Open Heart |
| Online Access: | https://openheart.bmj.com/content/8/2/e001707.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Type and Duration of Dual Antiplatelet Therapy in Complex Percutaneous Coronary Intervention
by: Dimitrios Alexopoulos, et al.
Published: (2020-11-01) -
Shortened Duration of Dual Antiplatelet Therapy Following Percutaneous Coronary Intervention: A Contemporary Clinical Review
by: Kevin S Tang, et al.
Published: (2023-12-01) -
Dual Antiplatelet Therapy Regimens and Duration for Intracranial Stenting Procedures: Literature Review
by: Milda Paliulytė, et al.
Published: (2023-11-01) -
Benefits and Harms of Extending the Duration of Dual Antiplatelet Therapy after Percutaneous Coronary Intervention with Drug-Eluting Stents: A Meta-Analysis
by: Chun Shing Kwok, et al.
Published: (2014-01-01) -
Short vs Standard Duration Dual Antiplatelet Therapy after Percutaneous Coronary Intervention with New-Generation Drug-Eluting Stents: A Meta- Analysis
by: Inam Ullah, et al.
Published: (2024-10-01)